pravastatin has been researched along with puromycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, S; Hirano, T; Komuro, F; Nagano, S; Takahashi, T | 1 |
| Li, J; Lu, Y; Zheng, X | 1 |
2 other study(ies) available for pravastatin and puromycin
| Article | Year |
|---|---|
Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis.
Topics: Animals; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Kinetics; Lipoproteins, VLDL; Male; Naphthalenes; Nephrosis; Pravastatin; Puromycin; Rats; Rats, Inbred Strains; Triglycerides | 1990 |
[Lipid-lowering effect of pravastatin on glomerulosclerosis protection and treatment].
Topics: Animals; Anticholesteremic Agents; Cholesterol; Glomerulosclerosis, Focal Segmental; Male; Nephrotic Syndrome; Pravastatin; Puromycin; Rats; Rats, Sprague-Dawley; Triglycerides | 1997 |